LITTLE information as yet is obtainable on the reliability of the pre-treatment glucose tolerance test as an indication of subsequent control of diabetes on chlorpropamide. Agreement on other indications of likely success (age of onset of diabetes over 40 years, absence of previous ketosis, relative stability, etc.) has been reached in numerous papers (Murray, et al.
LITTLE information as yet is obtainable on the reliability of the pre-treatment glucose tolerance test as an indication of subsequent control of diabetes on chlorpropamide. Agreement on other indications of likely success (age of onset of diabetes over 40 years, absence of previous ketosis, relative stability, etc.) has been reached in numerous papers (Murray, et al. (1958) , Hills and Abelove (1959) , Lowenthal, et al. (1959) , Ruiz-Gui'a (1959) , De Salcedo and Borges (1959) , Reyes, et al. (1959) , Duncan, et al. (1959) , Hamwi, et al. (1959) , and others). It must be admitted, however, that even in diabetes arising before the age of 40 and not apparently brittle there may be a good response to chlorpropamide. Yuen (1959) claims good results in young diabetics and Jackson and Oakley (1959) have been encouraged by the outcome of chlorpropamide treatment in a few diabetic adolescents and children diagnosed prior to the development of symptoms and ketosis. There would not appear, therefore, to be any absolute criterion of future control.
The present study was undertaken to investigate the initial glucose tolerance test in a series of diabetic patients treated with chlorpropamide and to compare this curve with the subsequent outcome after three months of treatment. A small group of brittle diabetics was similarly analysed for comparison.
MATERIAL AND METHODS.
A total of sixty patients were selected for study comprising forty-eight stable diabetics who had been treated on chlorpropamide and whose pre-treatment glucose tolerance curves were available. In addition the initial glucose tolerance tests of twelve patients with ketosis (brittle diaibetics) subsequently treated on insulin were used for comparison. Clinical details of some of these patients have previously been reported (Grant and Boyd, 1959) . In all instances true blood glucose estimations were performed on venous blood by a modification of the anthrone method of Handelsman and Sass (1956) .
Glucose tolerance curves.
Glucose tolerance tests were undertaken with the patients on average normal diet prior to testing. Using 50 gms. dextrose in 6 ozs. of warm water orally after fasting overnight and at rest in bed, a routine glucose tolerance test was performed with an initial fasting and four half-hourly post-prandial blood samples for estimation of blood sugar level (B.S.L.).
The curves were analysed for profile and the initial (fasting) level, the peak value and the steepness of the curve in each patient observed as indicating the severity of the diabetic state. The profile was assessed by means of a simple sign test, all blood sugar values differing by less than 11 mg./100 ml. being considered within the error of the technique. A plus was given for a rise above the previous level, a minus for a fall, and a zero for no change (Fig. 1) . REGULR /++++ /+++0 /++00 /+++-/++0- Response to chlorpropamide.
On completion of three months' chlorpropamide treatment the forty-eight patients were assessed and placed in suitable response categories (Table I) . Patients showing ketosis or obviously out of control were not, of course, continued on chlorpropamide but classified forthwith.
The criteria used were modified from those of Cardonnet, et al. (1959), and Sugar, et al. (1959) Initial glucose tolerance test curves. The analysis of results obtained in the sixty patients is shown in Table I , where "excellent" and "good" responses are combined as are "poor" results and "nonketotic failures" to form with "fair" response patients, three categories. The results in non-brittle and brittle patients are shown separately. Glucose tolerance test profile.
The patterns of shape encountered in the curves of the series are shown in Fig. 1 , where they have been somewhat arbitrarily divided into four groups. "Early fall" was classified if the only feature was a consistent fall at E or 1 hour. "Delayed rise" was considered descriptive of all curves not showing a rise in B.S.L. until one hour while "irregular" patterns showed prominent fluctuations in the B.S.L. All other responses were placed in the "regular" group. Although initially the four response categories-excellent and good, fair, poor and brittle were tabulated under the individual patterns encountered as shown in Fig. 1 , it was obvious that the scatter was too great and irregular for any trend to be seen and in Table I the analysis shows only the number of each category classified in the four profile groups defined above. Most patients can be seen to show the "regular" type of glucose tolerance curve with a steadily rising B.S.L. from the initial value and without a fall before 1j hours. This was the principal pattern present in both brittle and non-brittle diabetics.
The only suggestion presented from this analysis is that "irregular" profiles are proportionately more common in the poor response categories of chlorpropamide treated diaDetics, and that brittle patients tend towards more regular profiles.
Anialysis of the glucose tolerance test profile, however, proved disappointing and showed no clear distinction between the curves of either brittle or non-brittle diabetic patients nor could the type of curve be related to the subsequent response to chlorpropamide treatment. Initial and peak levels of glucose tolerance tests.
The means of the initial and peak values for the glucose tolerance test blood suigar levels with-their ranges are categorised also under the response groups in Table I . No significant difference could be found between the initial (fasting) levels in the diabetic response groups, any variation being between individual patients and unrelated to the chlorpropamide response or the presence of ketosis. The patient with the highest initial level of the series at 400 mg./100 ml. responded excellently to chlorpropamide while that with one of the lowest (142 mg./100 ml.) showed ketonuria. High initial values were associated with high peak B.S.Ls. The two highest peak B.S.Ls. were 560 and 564 mg./100 ml. These two patients fell into the excellent response category and brittle diabetic group respectively. Again the analysis of glucose tolerance test initial and peak blood sugar levels proved unhelpful in forecasting response to chlorpropamide.
DiscusSION.
Comparison of the initial and treatment glucose tolerance tests of diabetic patients treated on chlorpropamide has been undertaken by a number of workers. Investigations have shown that the mean glucose tolerance curve is depressed in a manner parallel to the mean pre-treatment contour; the suggestion being that chlorpropamide causes a general improvement in glucose tolerance while not altering the utilisation of glucose as shown by the mean profile of glucose tolerance tests (De Salcedo and Borges (1959) , Lundback, et al. (1959) , Dobson, et al. (1959) , Grant and Boyd (1959) . Reyes, et al. (1959) , describe flattening and depression of the curve in ten patients after six days' chlorpropamide treatment, while Stowers, et al. (1959) , suggest that the fasting blood glucose is reduced to a greater extent than the post-prandial levels on chlorpropamide. A possible relationship between the initial glucose tolerance test and the patient's response to treatment is not considered in the above papers.
Little information is available regarding the reliability of the oral glucose tolerance test as an indication of the severity of diabetes. In the interpretation of the test Joslin, et al. (1959) , stress the importance of such factors as the previous physical and nutritional state, the patient's age, absence of infection, 41 N state of mobility, absence of associated thyroid or pituitary overactivity and the ensurence of a normal balance of dietary protein, carbohydrate and fat. Assuming also that there is no defect of absorption, the initial hyperglycaemia and the shape of the post-ingestion glucose tolerance curve in the diabetic patient are due to lack of insulin and the consequent failure of the body to respond to the increase in body fluid glucose. The final fall of the blood sugar is due mainly to the excretion of glucose in the urine (Wright, 1957) .
Blotner (1947) states that interpretation of the oral glucose tolerance test by the peak blood sugar level and rate of fall is probably the safest method in diagnosis. He considers the curve to be consistent enough to be of great value in the diagnosis of diabetes and groups patients into degrees of severity on the , 1958 -190 ... 218 ... 230 ... 246 ... 258 contour of the glucose tolerance test as does Lawrence (1947) . Except in patients with malabsorption neither Blotner (1947) nor Lawrence (1947) found any advantage in the various forms of intravenous test. Increased precision in the glucose tolerance test by the exclusion of non-glucose reducing substances (estimated in the Folin-Wu method) is stressed by Mosenthal (1947) , while Beckwith (1947) is concerned mainly with the rate of fall in the blood sugar at two hours in the interpretation of the glucose tolerance curve. In spite of the many influencing factors, Bodansky and Bodansky (1947) consider the response in the diabetic patient to be usually quite distinctive though with considerable variation, depending in large measure on the severity of the diabetes. Varley (1958) , while also commenting on possible fallacies, considers the glucose tolerance curve of considerable use in investigating abnormnalities of carbohydrate metabolism. Indeed there is as yet no better means of diagnosis and of assessing the severity of diabetes.
From the above information it was felt, therefore, that the pre-treatment glucose tolerance test profile and initial and peak blood sugar level results might correlate with the outcome of chlorpropamide treatment and be useful in predicting results. Unfortunately, no relationship could be demonstrated on the most careful comparison. The reason for this lies in the unreliability of the test even when repeated in the same individual. Most discrepancies in the repeated glucose tolerance test have been noted in investigations in non-diabetic patients. Freeman, et al. (1942) , wlhile remarking on the sparcity of information on the reliability of the oral glucose tolerance test in normal subjects, found average variation in the fasting blood sugar of 9 (range 0-30) mg./100 ml., 31 (range 0-90) mg./ 100 ml. at 1 hour and 20 (range 0-50) mg./100 ml. at 2 hours on repeating the standard oral glucose tolerance test on 35 non-diabetic patients after an average interval of four to seven weeks. In the diabetic patient Bodansky and Bodansky (1947) and Stewart and Dunlop (1949) refer to divergence in the results of glucose tolerance tests repeated on the same individual after short time intervals, and Anderson, et al. (1956) , in 100 unselected persons, found mean variations in the post-absorptive blood sugar of 22.2 mg./100 ml. when specimens were taken at two-minute intervals. Examples of the variation in glucose tolerance test results in four of our own patients are shown in Table II 
